Resveratrol and many HDAC inhibitors have been individually studied also against ALS (Chuang et al., 2009; Carrera-Juliá et al., 2020; Shukla and Tekwani, 2020; Klingl et al., 2021; Novak et al., 2021). The gene discussed is HDAC9; the disease is amyotrophic lateral sclerosis.